GGrantIndex
← Leaderboards

Jan A. Nolta

Children'S Hospital Los Angeles

Google Scholar ↗PubMed ↗ORCID ↗
$14,435,430
Attributed
$17,521,531
Total exposure
12
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,521,531 · 12

By mechanism

R01$12,632,164 · 5
R24$2,811,872 · 1
P50$742,080 · 1
S10$499,785 · 1
U54$443,652 · 1
R21$306,000 · 1

Top collaborators

Others in their field

Top investigators on “Hematopoietic Stem Cells”

Research focus

Hematopoietic Stem CellsCellsScid MouseMouse ModelImmuneBone MarrowProteinsAreaCell TypeHuman TissueFundingNod MouseAdultHepatocyte Growth FactorLaboratoriesPolymerase Chain ReactionIn VivoStemHuntington DiseaseApoptosisTransfection /Expression VectorPhenotypeCell TherapyNeurodegenerative Disorders

Grant awards (53)

MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE$346,046
R01 · FY2025 · NS
MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE$377,253
R01 · FY2024 · NS
MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE$388,921
R01 · FY2023 · NS
MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE$388,921
R01 · FY2022 · NS
Cell and Gene Therapy for Neurodevelopmental Disorders Conference$10,000
R13 · FY2021 · NS · contact PI
Novel immune deficient mouse models of Huntington's disease$602,990
R24 · FY2020 · OD · contact PI
Novel immune deficient mouse models of Huntington's disease$639,616
R24 · FY2019 · OD · contact PI
MSCs engineered to produce Brain-Derived Neurotrophic Factor for the Treatment of Huntington's disease$597,167
R01 · FY2019 · NS · contact PI
Optimization of humanized mouse models using mobilized peripheral blood stem cells$325,626
R24 · FY2019 · OD · contact PI
Increasing Flow Cytometry Capabilities and Throughput to Assess Impact of Engrafted Human Immune Cells$62,903
R24 · FY2019 · OD · contact PI
MSCs engineered to produce Brain-Derived Neurotrophic Factor for the Treatment of Huntington's disease$621,833
R01 · FY2018 · NS · contact PI
Novel immune deficient mouse models of Huntington's disease$565,170
R24 · FY2018 · OD · contact PI
Novel immune deficient mouse models of Huntington's disease$46,108
R24 · FY2018 · OD · contact PI
MSCs engineered to produce Brain-Derived Neurotrophic Factor for the Treatment of Huntington's disease$630,190
R01 · FY2017 · NS · contact PI
Novel immune deficient mouse models of Huntington's disease$569,459
R24 · FY2017 · OD · contact PI
Direct cell to cell transfer of microRNA for tissue repair$533,770
R01 · FY2015 · GM · contact PI
Direct cell to cell transfer of microRNA for tissue repair$533,770
R01 · FY2014 · GM · contact PI
Direct cell to cell transfer of microRNA for tissue repair$517,757
R01 · FY2013 · GM · contact PI
Direct cell to cell transfer of microRNA for tissue repair$533,770
R01 · FY2012 · GM · contact PI
Direct cell to cell transfer of microRNA for tissue repair$532,352
R01 · FY2011 · GM · contact PI
Shared LSRII Cytometer Equipment Application - UC Davis Stem Cell Program$499,785
S10 · FY2010 · RR · contact PI
Functional dissection of human adipose and bone marrow-derived MSC phenotypes$382,500
R01 · FY2010 · HL · contact PI
STEM CELL THERAPIES FOR HUNTINGTON?S DISEASE$75,978
P51 · FY2010 · RR · contact PI
Functional dissection of human adipose and bone marrow-derived MSC phenotypes$382,500
R01 · FY2009 · HL · contact PI
Immunodeficient mouse model of stem cell plasticity$296,512
R01 · FY2009 · DK · contact PI
Immunodeficient mouse model of stem cell plasticity$296,512
R01 · FY2008 · DK · contact PI
Immunodeficient mouse model of stem cell plasticity$302,564
R01 · FY2007 · DK · contact PI
Core D-- Animal core$96,320
U54 · FY2007 · HL · contact PI
Functional dissection of human A-MSC vs BM-MSC phenotype$373,511
R01 · FY2006 · HL · contact PI
Immunodeficient mouse model of stem cell plasticity$312,625
R01 · FY2006 · DK · contact PI
Ex Vivo Stem Cell Manipulation and Human Hematopoiesis$289,471
R01 · FY2006 · DK · contact PI
Core D-- Animal core$117,665
U54 · FY2006 · HL · contact PI
Functional dissection of human A-MSC vs BM-MSC phenotype$382,500
R01 · FY2005 · HL
Ex Vivo Stem Cell Manipulation and Human Hematopoiesis$296,439
R01 · FY2005 · DK
Core D-- Animal core$115,759
U54 · FY2005 · HL
Immunodeficient Mouse Model of Stem Cell Plasticity$382,500
R01 · FY2004 · DK
Functional dissection of human A-MSC vs BM-MSC phenotype$382,500
R01 · FY2004 · HL
Ex Vivo Stem Cell Manipulation and Human Hematopoiesis$296,439
R01 · FY2004 · DK
HGF Induces Robust Human Thymopoiesis in Mice$153,000
R21 · FY2004 · DK
Core D-- Animal core$113,908
U54 · FY2004 · HL
Immunodeficient Mouse Model of Stem Cell Plasticity$382,500
R01 · FY2003 · DK
Functional dissection of human A-MSC vs BM-MSC phenotype$382,500
R01 · FY2003 · HL
Ex Vivo Stem Cell Manipulation and Human Hematopoiesis$365,288
R01 · FY2003 · DK
HGF Induces Robust Human Thymopoiesis in Mice$153,000
R21 · FY2003 · DK
Immunodeficient Mouse Model of Stem Cell Plasticity$382,500
R01 · FY2002 · DK
REGULATION OF HUMAN HEMATOPOIETIC STEM CELL CYCLE INDUCTION$185,520
P50 · FY2002 · HL
Immunodeficient Mouse Model of Stem Cell Plasticity$373,999
R01 · FY2001 · DK
REGULATION OF HUMAN HEMATOPOIETIC STEM CELL CYCLE INDUCTION$185,520
P50 · FY2001 · HL
REGULATION OF HUMAN HEMATOPOIETIC STEM CELL CYCLE INDUCTION$185,520
P50 · FY2001 · HL
EX VIVO STEM CELL MANIPULATION AND HUMAN HEMATOPOIESIS$184,262
R01 · FY2001 · DK
Immunodeficient Mouse Model of Stem Cell Plasticity$1
R01 · FY2001 · DK
REGULATION OF HUMAN HEMATOPOIETIC STEM CELL CYCLE INDUCTION$185,520
P50 · FY2000 · HL
EX VIVO STEM CELL MANIPULATION AND HUMAN HEMATOPOIESIS$182,791
R01 · FY2000 · DK